Riskpilot← Back to searchSign inGet full accessFIRBENT TERAPI AS
ASActiveOrg 813124912Blåfjellveien 29, 4019 StavangerOther human health activities n.e.c. · NACE 8699Est. 20141 employeeswww.firbentterapi.no
Revenue 2024
NOK 493K
+14% vs 2023
EBITDA margin
-11.9%
+78% vs 2023
Equity ratio
-397.8%
Financial strength
Net profit 2024
NOK -58K
+80% vs 2023
| Revenue | NOK 493K | +14% |
| EBITDA | NOK -58K | +78% |
| Net profit | NOK -58K | +80% |
| Total assets | NOK 95K | +35% |
| Equity | NOK -378K | -18% |
| Employees | 1 | — |
Legal name
FIRBENT TERAPI AS
Org number
813124912
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
25. januar 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Gjennom helsefremmende arbeid med bruk av terapihunder og andre dyr skal selskapet bidra til å bedre menneskers fysiske og psykiske helse. Selskapet bruker også dyr som en pedagogisk ressurs til å skape en arena for læring og mestring. Selskapet har ikke som formål å oppnå økonomisk vinning for seg selv eller sine eiere. Det skal ikke deles ut utbytte til aksjonærer. Eventuelt overskudd i selskapet skal brukes til å realisere selskapets formål. Ved likvidasjon skal eventuelt overskudd ikke utdeles til aksjonærene, men til et allmennyttig formål etter styrets beslutning.
Address
Blåfjellveien 29, 4019 Stavanger
Website
www.firbentterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 501 | 677 | 609 | 431 | 493 |
| Staff expenses | −121 | −132 | −131 | −199 | −140 |
| EBITDA | −6 | 122 | 91 | −261 | −58 |
| Depreciation & amort. | −0 | −0 | −10 | −10 | −0 |
| EBIT | −6 | 122 | 81 | −270 | −58 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | 122 | 81 | −270 | −58 |
| Tax | −0 | −0 | −23 | 23 | −0 |
| Net profit | −6 | 122 | 104 | −294 | −58 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 171 | 274 | 291 | 70 | 95 |
| Equity | −253 | −131 | −26 | −320 | −378 |
| Long-term debt | 0 | 0 | 0 | 0 | 35 |
| Short-term debt | 424 | 404 | 317 | 390 | 439 |
| Total debt | 424 | 404 | 317 | 390 | 474 |
EBITDA margin
-11.9%
This company
15.8%
Market median
-175% vs market
20202024
Equity ratio
-397.8%
This company
38.2%
Market median
-1141% vs market
20202024
Return on equity
-5842900.0%
This company
18.4%
Market median
-31754991% vs market
20202024
Net profit margin
-11.9%
This company
8.1%
Market median
-247% vs market
20202024
Asset turnover
5.18×
This company
1.12×
Market median
+362% vs market
20202024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HK Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FIRBENT TERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helle Karin Barstad | Chief Executive Officer | 0 companies |